1. Home
  2. MRUS vs IAG Comparison

MRUS vs IAG Comparison

Compare MRUS & IAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • IAG
  • Stock Information
  • Founded
  • MRUS 2003
  • IAG 1990
  • Country
  • MRUS Netherlands
  • IAG Canada
  • Employees
  • MRUS N/A
  • IAG N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • IAG Precious Metals
  • Sector
  • MRUS Health Care
  • IAG Basic Materials
  • Exchange
  • MRUS Nasdaq
  • IAG Nasdaq
  • Market Cap
  • MRUS 5.1B
  • IAG 4.6B
  • IPO Year
  • MRUS 2016
  • IAG 1996
  • Fundamental
  • Price
  • MRUS $68.95
  • IAG $11.02
  • Analyst Decision
  • MRUS Strong Buy
  • IAG Buy
  • Analyst Count
  • MRUS 13
  • IAG 7
  • Target Price
  • MRUS $92.15
  • IAG $9.38
  • AVG Volume (30 Days)
  • MRUS 629.8K
  • IAG 11.5M
  • Earning Date
  • MRUS 10-30-2025
  • IAG 11-06-2025
  • Dividend Yield
  • MRUS N/A
  • IAG N/A
  • EPS Growth
  • MRUS N/A
  • IAG 452.66
  • EPS
  • MRUS N/A
  • IAG 1.37
  • Revenue
  • MRUS $56,228,000.00
  • IAG $1,966,800,000.00
  • Revenue This Year
  • MRUS $48.69
  • IAG $57.87
  • Revenue Next Year
  • MRUS $3.15
  • IAG $14.35
  • P/E Ratio
  • MRUS N/A
  • IAG $8.02
  • Revenue Growth
  • MRUS 59.77
  • IAG 57.81
  • 52 Week Low
  • MRUS $33.19
  • IAG $4.44
  • 52 Week High
  • MRUS $70.65
  • IAG $11.58
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 57.97
  • IAG 75.14
  • Support Level
  • MRUS $66.49
  • IAG $10.76
  • Resistance Level
  • MRUS $69.63
  • IAG $11.58
  • Average True Range (ATR)
  • MRUS 2.46
  • IAG 0.43
  • MACD
  • MRUS -0.07
  • IAG 0.07
  • Stochastic Oscillator
  • MRUS 78.37
  • IAG 78.35

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About IAG Iamgold Corporation

Iamgold Corp is a mid-tier gold mining company. The company operating gold mines are divided into geographic segments such as Cote Gold mine - Canada, Burkina Faso - Essakane mine, Westwood mine - Canada. The company's s non-gold mine segments are Exploration and evaluation and development, and Corporate - which includes royalty interests. The company generates the majority of its revenue from the Cote Gold mine segment.

Share on Social Networks: